R Squared’s Nuvation Bio NUVB Stock Holding History

R Squared’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,737	Closed	-$50.8K	–	658
2025 Q3	$50.8K	Buy	+13,737	New	+$37.4K	0.02%	489
2025 Q1	–	Sell	-300	Closed	-$798	–	1088
2024 Q4	$798	Buy	+300	New	+$772	﹤0.01%	1521

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

R Squared's NUVB Position: Q4 2025 in Review

R Squared sold out of Nuvation Bio (NUVB) in Q4 2025, closing a stake of 13,737 shares — an estimated $50.8K sold.

R Squared first reported a position in NUVB in Q4 2024 and held it in 2 quarters. The position peaked at $50.8K in Q3 2025. 223 funds tracked by Wall St. Rank hold NUVB as of Q4 2025.

R Squared reported no remaining Nuvation Bio position as of Q4 2025 after selling out during the quarter.
R Squared sold 13,737 Nuvation Bio shares in Q4 2025, an estimated $50.8K.
R Squared first reported a position in Nuvation Bio in Q4 2024 and held it in 2 quarters.
R Squared's Nuvation Bio position peaked at $50.8K in Q3 2025.
223 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2025.

Based on R Squared's 13F filing for Q4 2025, filed 30 Jan 2026.